medigraphic.com
SPANISH

Archivos de Neurociencias

Instituto Nacional de Neurología y Neurocirugía
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 4

<< Back Next >>

Arch Neurocien 2019; 24 (4)

Scale of cognitive symptoms in depression (EsADFUN)

Peña-De León E, Mejía-Martínez K, Ruíz-Chow ÁA, Monsiváis-Ríos R, Álvarez-Bernal CA
Full text How to cite this article

Language: Spanish
References: 13
Page: 14-22
PDF size: 359.93 Kb.


Key words:

attention, autoevalutation, depression, scale, memory, México.

ABSTRACT

Introduction. To measure the cognitive dimenssion of depression is a relevant matter because is critical in remission and to predict relapse. Objective. Elaboration and validation of a scale to measure cognitive symptoms in depression, that is complete, easy and practical to apply in mexican depressed patients. Methods. We made two depression expert´s consensus meetings to gather the ítems to include in the scale and to get the construct validation. We applied the Antoevalutation Scale for Depression and Functionality (EsADFUN) to a group of depressed patients between 18 and 65 years old and to a control group paired by age, gender and education. As well as the Internatonal Neuropsychiatric Interview (MINI), Beck depression scale, Patient Helath Questionnaire (PHQ-9) and Digit Symbol Substitution Test (DSST). Results. EsADFUN got construct and discriminant validation, as well as intern consistency between its ítems, with a sensibility of 97% and specificity of 83%. It had a mild to moderate correlation, but statistically significant between the intensity of the depression sympttoms and the cognitive afection. It had a positive correlation between the EsADFUN ítem 10 and the DSST, considering it aceptable and valid to evaluate processing speed. Discussion and conclussion. EsADFUN es a complete and valid scale to measure cognitive symptoms in depressed patients for clinical and research purposes.


REFERENCES

  1. American Psychiatric Association (APA) (2014). Manual Diagnóstico y Estadístico de los Trastornos Mentales DSM- 5. Barcelona, España. Masson.

  2. Baader T, Molina JL, Venezian S, Rojas C, Farías R, Fierro-Freixenet C, Backenstrass M, Mundt C. (2012)Validación y utilidad de la encuesta PHQ-9 (Patient Health Questionnaire) en el diagnóstico de depresión en pacientes usuarios de atención primaria en Chile. Revista Chilena de Neuropsiquiatría; 50 (1):10-22

  3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J.(1961) An inventory for measuring depression. Archives of general psychiatry; 4: 561-571. ePROVIDE. URL: https://eprovide.mapi-trust.org/instruments/perceived-deficitsquestionnaire- depression#basic_description. (10.07.2018)

  4. Fehnel SE, Forsyth BH, DiBenedetti DB, Danchenko N, François C, Breivig T. Patient-centered assesment of cognitive symptoms of depression. CNS Spectr 2016; 21(1):43-52. doi: 10.1017/S1092852913000643.

  5. Ferrando L, Bobes J, Gibert M, Soto M, Soto O. M.I.N.I. Mini International Neuropsychiatric Interview. Versión en español 5.0.0.DSM-IV. Instituto IAP, Madrid 1998.

  6. Gualtieri CT, Morgan DW. The Frequency of Cognitive Impairment in Patients With Anxiety, Depression and Bipolar Disorder: An Unaccounted Source of Variance in Clinical Trials. J Clin Psychiatry 2008; 69(7):1122-1130.

  7. Marazziti D, Consoli G, Picchetti M, Carlini M, Faravelli L. Cognitive impairment in major depression. Eur J Pharmacol 2010; 626(1):83-6. doi: 10.1016/j.ejphar.2009.08.046: 83-86.

  8. McIntyre RS, Soczynska JZ, Woldeyohannes HO, Alsuwaidan MT, Cha DS, Carvalho AF, Jerrel JM, Dale RM, Gallaugher LA, Muzina DJ, Kennedy SH. (2015) The impact of cognitive impairment on perceived workforce performance: Results from the International Mood disorders Collaborative Project. Comprenhensive Psychiatry 2015; 56, 279- 282.

  9. McIntyre RS, Best MW, Bowie CR, et.al. (2017) The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder. J Clin Psychiatry 2017; 78(7):873– 881. doi: 10.4088/JCP.16m11329.

  10. Organización Mundial de la Salud (OMS). (1992) CIE-10. Décima revisión de la clasificación internacional de las enfermedades. Trastornos mentales y del comportamiento. Descripción clínicas y pautas para el diagnóstico. Madrid, España. Meditor.

  11. Smith A. Symbol Digit Modalities Test. Los Angeles: Western Psychological Services 1973.

  12. Sullivan MJL, Edgley K, Deboux E. A Survey of Multiple Sclerosis part 1: Perceived Cognitive Problems and Compensatory Strategy Use. Canadian Journal of Rehabilitation 1990: 99-105.

  13. World Health Organization. URL: http://www.who.int/es/news-room/fact-sheets/detail/depression (8.07.2018)




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Neurocien. 2019;24